BALTIMORE (WJZ) — The FDA on Friday approved Moderna’s COVID-19 vaccine for emergency use.

Researchers at the University of Maryland School of Medicine were among those to work on multiple vaccine trials, including Moderna’s.

READ MORE: ‘Tremendous Loss’ Violence Prevention Worker Killed In East Baltimore Mass Shooting


Dr. Matthew Laurence, a COVID-19 vaccine researcher from the school’s Center for Vaccine Development, said Moderna’s vaccine performed better than expected.

READ MORE: Weather Whiplash: Winter Weather Still Threatens Road Conditions

“The expectation was far lower as far as how well the vaccine would protect, but the fact that it gave more than 90% efficacy is just astounding,” he said.

Moderna is the second company to be granted emergency use authorization for a coronavirus vaccine from the FDA. Pfizer was granted emergency use on December 12.

MORE NEWS: Cycle Of Crime In Baltimore Highlights BPD Shortcomings, Judge Says

For the latest information on coronavirus go to the Maryland Health Department’s website or call 211. You can find all of WJZ’s coverage on coronavirus in Maryland here.

CBS Baltimore Staff